VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Share Price, News & Analysis

Company Overview

CYBG PLC, through its subsidiaries, provides retail and business banking products and services to individuals and businesses under the Clydesdale Bank, Yorkshire Bank, B, and Virgin Money brands in the United Kingdom. It operates through SME Banking and Retail Banking segments. The SME Banking segment offers a range of banking products and services, including business current accounts; and secured and unsecured term loans, business overdrafts, and invoice and asset financing products and services. It also provides international trade services, such as import loans, export loans, documentary collections, currency guarantees, and letters of credit for securing trade; and current account facilities comprising debit cards, cheque books, regular statements, direct debits, and standing orders, as well as day to day and online banking services. This segment serves business customers in the small business, commercial, corporate, and structured finance markets. The Retail Banking segment offers personal current accounts, savings accounts, and term deposits; occupied mortgage loans and BTL loans, unsecured personal loans, and overdrafts, as well as credit card products; and insurance and investment products. The company was founded in 1838 and is based in Leeds, the United Kingdom.

Key Stats

• Today's Range: 16.33 to 16.43
• 50-Day Range: 15.87 to 17
• 52-Week Range: 15.18 to 17.74
• Volume: 115 shs
• Average Volume: 336 shs
• Market Capitalization: £235.37 million
• P/E Ratio: N/A
• Dividend Yield: 0.18%
• Price Target: N/A
• Consensus Rating: N/A

CYBG Stock Analysis - Frequently Asked Questions

How have CYBG shares performed this year?

VanEck Bionic Engineering UCITS ETF A Acc's stock was trading at GBX 16.40 at the start of the year. Since then, CYBG shares have increased by 0.1% and is now trading at GBX 16.41.
View the best growth stocks for 2024 here.

How do I buy shares of VanEck Bionic Engineering UCITS ETF A Acc?

Shares of CYBG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of VanEck Bionic Engineering UCITS ETF A Acc own?

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Bionic Engineering UCITS ETF A Acc investors own include National Australia Bank (NAB), Virgin Money UK (VMUK), G-III Apparel Group (GIII), Alphabet (GOOG), Ionis Pharmaceuticals (IONS), Svenska Handelsbanken AB (publ) (SVNLY) and Western Union (WU).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Finance
• Industry: Banks - Regional - Europe
• Sub-Industry: N/A
• Current Symbol: LON:CYBG
• CUSIP: N/A
• CIK: N/A
• Web: www.cybg.com
• Phone: +44-141-2324763
• Fax: N/A
• Employees: 5,762
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 0.01
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: £1.24 billion
• Price / Sales: 0.19
• Cash Flow: GBX 122.72 per share
• Price / Cash Flow: 0.13
• Book Value: GBX 355.10 per share
• Price / Book: 0.05

Miscellaneous

• Outstanding Shares: 1,434,489,984
• Free Float: N/A
• Market Cap: £235.37 million
• Optionable: Not Optionable
• Beta: N/A